TONIX PHARMACEUTICALS HOLDIN (TNXP) Institutional Ownership Changes & 13F Activity
TONIX PHARMACEUTICALS HOLDIN (TNXP). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Point72 Asset Management, L.P., Millennium Management Llc, Aqr Capital Management Llc, Ishara Investments Lp, and Citadel Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Sell | -272,853 | -58.2% | 195,859 | $2.50M | Q2 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -566 | -74.8% | 191 | $2.44K | Q2 2026 | Aug 24, 2026 |
| Mercer Global Advisors Inc | Buy | +23,818 | — | 23,818 | $303.92K | Q2 2026 | Aug 19, 2026 |
| Point72 Asset Management, L.P. | Buy | +1,041,338 | +830.3% | 1,166,752 | $14.89M | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +747,259 | +340.2% | 966,932 | $12.34M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Buy | +721,387 | +447.5% | 882,595 | $11.26M | Q2 2026 | Aug 14, 2026 |
| Ishara Investments Lp | Buy | +338,250 | — | 338,250 | $4.32M | Q2 2026 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | Sell | -180,491 | -57.6% | 132,591 | $1.69M | Q2 2026 | Aug 14, 2026 |
| Susquehanna Portfolio Strategies, Llc | Buy | +65,024 | — | 65,024 | $829.71K | Q2 2026 | Aug 14, 2026 |
| Trexquant Investment Lp | Buy | +63,635 | — | 63,635 | $811.98K | Q2 2026 | Aug 14, 2026 |
| Jacobs Levy Equity Management, Inc | Buy | +57,943 | — | 57,943 | $739.35K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Buy | +45,301 | +85.4% | 98,356 | $1.26M | Q2 2026 | Aug 14, 2026 |
| Quarry Lp | Buy | +41,250 | — | 41,250 | $526.35K | Q2 2026 | Aug 14, 2026 |
| Invesco Ltd. | Buy | +37,691 | — | 37,691 | $480.94K | Q2 2026 | Aug 14, 2026 |
| Cerity Partners Llc | Buy | +31,074 | — | 31,074 | $396.51K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +28,812 | — | 28,812 | $367.64K | Q2 2026 | Aug 14, 2026 |
| Sei Investments Co | Buy | +25,501 | +232.4% | 36,472 | $465.38K | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +22,823 | +76.6% | 52,613 | $671.34K | Q2 2026 | Aug 14, 2026 |
| Bridgeway Capital Management, Llc | Buy | +20,000 | — | 20,000 | $255.20K | Q2 2026 | Aug 14, 2026 |
| Man Group Plc | Buy | +18,669 | — | 18,669 | $238.22K | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +13,455 | +45.5% | 43,034 | $549.11K | Q2 2026 | Aug 14, 2026 |
| Alliancebernstein L.P. | Buy | +10,960 | +83.9% | 24,030 | $330.41K | Q2 2026 | Aug 14, 2026 |
| Larson Financial Group Llc | Buy | +9,725 | — | 9,725 | $124.09K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +6,789 | +78.7% | 15,418 | $196.73K | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +5,547 | +40.1% | 19,363 | $248.00K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Buy | +802 | +1359.3% | 861 | $11.00K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +797 | +12.2% | 7,346 | $93.74K | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Buy | +712 | +48.9% | 2,167 | $27.65K | Q2 2026 | Aug 14, 2026 |
| Metlife Investment Management, Llc | Buy | +529 | +6.2% | 9,119 | $116.36K | Q2 2026 | Aug 14, 2026 |
| Group One Trading Llc | Sell | -507 | -66.7% | 253 | $3.23K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about TNXP activity
Which institutional owners are buying TNXP?
Institutional owners buying TNXP include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TNXP activity?
"Buy" means an investor increased their reported position in TNXP compared to the prior reporting period. This reflects growing exposure to TONIX PHARMACEUTICALS HOLDIN (TNXP) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TNXP increasing?
Institutional interest in TNXP can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.